VAERS Explorer
Back to explore

Report #2879781

Received Dec 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
85 yrs
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK—IM

Symptoms (1)

Myocarditis

Symptom narrative

myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (myocarditis) in an 85-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (myocarditis) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (myocarditis) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medication was reported. The patient experienced myocarditis episode after her vaccines, 3 of them, a couple of years ago. The patient was being forced by healthcare organization to have another one. The reporter asked why Moderna was making elderly people get the vaccines when they spike all over the body. The reporter also asked why Moderna was killing people. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.; Reporter's Comments: The case was assessed as possibly related to suspected vaccine, as the event is compatible with safety profile SPIKEVAX NOS, however missing information regarding medical history, concomitant medications and onset latency preclude proper medical assessment. The benefit-risk relationship of the mRNA-1273 is not affected by this report.